Arthex Biotech S.L. is a biotechnology company based in Paterna, Spain, that specializes in the development of antisense RNA therapies for genetic diseases. Founded in 2019 as a spin-off from the University of Valencia, the company focuses on addressing unmet medical needs through innovative treatments targeting microRNAs, which are implicated in various disorders, including neuromuscular diseases. With a team experienced in drug discovery and strong support from leading scientific and clinical advisors, Arthex Biotech aims to provide effective therapies for patients suffering from rare and challenging conditions.
Voiseed is an AI-based company founded in 2020 and headquartered in Milan, Italy, specializing in the development of a virtual voice engine for speech synthesis. The company's software utilizes advanced generative AI technologies to replicate human emotions and prosody, creating highly expressive virtual voices. Voiseed's cloud-based platform offers a universal voice model and an emotional data set, allowing users to customize vocal expressions and perform multilingual voice conversions for various projects. This innovative tool enables creators in the dubbing industry to design voice textures that meet their specific requirements, significantly reducing costs, time, and complexity in the production process.
ReLearn is a startup focused on leveraging artificial intelligence to assist companies and municipalities in minimizing their environmental impact by monitoring waste production. Utilizing a plug-and-play sensor called NANDO, which is installed on trash bins, ReLearn gathers precise data on the quantity and quality of waste generated daily. This data facilitates the creation of detailed sustainability reports and enhances awareness of environmental issues among corporate and civic stakeholders. The company employs gamification techniques to engage users and promote environmentally responsible behaviors. ReLearn aims to support visionary organizations in achieving their ZERO WASTE goals and adhering to key Sustainable Development Goals. By transforming ordinary bins into smart waste management systems, ReLearn enables clients to automate processes and improve efficiency while reducing carbon emissions and operational costs associated with improper waste disposal. The company has garnered recognition for its innovative approach, being a winner of the European Social Innovation Competition in 2022.
SILEANE specialists of robotics and vision.
Tilkal is a Paris-based company founded in 2017 that specializes in developing a software platform for traceability across supply chains. Its end-to-end, real-time traceability solution integrates permissioned blockchain networks with big data to facilitate secure and verifiable data sharing among various supply chain stakeholders. The platform allows businesses to record traceability data of physical products in a ledger, enhancing compliance, transparency, and consumer trust. Tilkal's technology is actively utilized by major corporations such as Groupe Casino and Danone, providing them with the tools to analyze traceability data, manage sourcing risks, and demonstrate environmental, social, and governance (ESG) commitments. By focusing on resilience, sustainability, and ethical practices, Tilkal aims to improve the overall integrity of supply chains across diverse industries.
ELEM Biotech
Grant in 2022
ELEM is a start-up company conceived at the Barcelona Supercomputing Center (BSC) and host of MareNostrum supercomputer. ELEM is co-founded by BSC researchers Mariano Vázquez, Guillaume Houzeaux, José María Cela, and business consultant Chris Morton. The company has developed Alya Red, a set of simulation tools, which following a “Software-as-a-Service” model deployed in the cloud, focuses on medical devices and pharmaceutical industries. Alya Red simulates cardiovascular or respiratory systems on “virtual patients”. Combining high performance computing, computational biomechanics and data analysis, these computational avatars can be used by biomedical sector companies and clinicians to elaborate diagnoses, plan treatments, improve drug delivery and action, optimise medical devices, etc. ELEM headquarters are in Barcelona.
Releaf Paper is a producer of sustainable paper products from fallen leaves. They work on the task of finding a solution to achieve sustainability in the production of paper using new raw materials - fallen leaves, instead of wood.
xFarm S.R.L. is an Italian startup established in 2017, focusing on the digitalization of agriculture. Based in Alessandria, the company designs and develops a comprehensive software-as-a-service platform tailored for farmers and stakeholders in the agrifood industry, including agronomists, dealers, cooperatives, and insurance providers. xFarm's offerings include a user-friendly agricultural application available on mobile and desktop, advanced premium modules, and an analytics dashboard for professionals. The platform is enhanced by a range of Internet of Things (IoT) sensors that are optimized and connected to support effective farm management. By providing innovative tools that address the complexities of modern agriculture, xFarm aims to simplify processes and improve operational efficiency in the agricultural sector.
Ganymed Robotics SAS, a medical device company, focuses on the development of robotics technologies for orthopedic surgeons. It develops a therapeutic device to enhance surgical precision in knee replacement surgery. The company was incorporated in 2018 and is based in Paris, France.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Methinks Software, founded in 2016 and based in Barcelona, Spain, specializes in developing artificial intelligence medical software focused on stroke diagnosis and treatment. Utilizing advanced techniques from Google's deep learning framework, TensorFlow, the company analyzes neuroimaging to provide timely and accurate diagnoses of brain-related diseases, particularly acute strokes. Its medical imaging platform enables rapid assessment from non-contrast CT scans, streamlining the diagnosis process and facilitating improved communication between radiologists, hospitals, stroke units, and healthcare professionals. By bypassing the need for contrast CT scans, Methinks aims to reduce time-to-treatment, ultimately enhancing clinical outcomes and patient care in emergency settings.
Tucuvi Care, S.L. is a Madrid-based company that specializes in developing artificial intelligence and voice technology solutions for the healthcare sector. Founded in 2019, Tucuvi's platform serves a variety of clients, including hospitals, insurance companies, telecare services, and patient associations. The company offers an intelligent virtual caregiver designed to support older adults in maintaining their independence at home. Its technology provides personalized care through features such as medication reminders, treatment guidelines, cognitive stimulation exercises, and assessments of caregiver satisfaction. Additionally, Tucuvi's platform aids healthcare professionals by enhancing their ability to monitor and care for patients, particularly those with chronic conditions like heart failure.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Orixha has developped an innovative device for cooling patients within few minutes and thus improve their prognosis by using a dedicated liquid ventilator able to perform safe and efficient total liquid ventilation. This method consists in filling the lungs with liquid perfluorocarbons and due to the high gases solubility and the large pulmonary sufaces can use the lungs as heat exchanger.
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
xFarm S.R.L. is an Italian startup established in 2017, focusing on the digitalization of agriculture. Based in Alessandria, the company designs and develops a comprehensive software-as-a-service platform tailored for farmers and stakeholders in the agrifood industry, including agronomists, dealers, cooperatives, and insurance providers. xFarm's offerings include a user-friendly agricultural application available on mobile and desktop, advanced premium modules, and an analytics dashboard for professionals. The platform is enhanced by a range of Internet of Things (IoT) sensors that are optimized and connected to support effective farm management. By providing innovative tools that address the complexities of modern agriculture, xFarm aims to simplify processes and improve operational efficiency in the agricultural sector.
Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
Perha Pharmaceuticals is a biotechnology company dedicated to the research and development of innovative therapies aimed at addressing hearing loss and cognitive disorders. The company focuses on preventing cisplatin-induced hearing loss and developing treatments for cognitive conditions related to Down syndrome and Alzheimer's disease. Perha Pharmaceuticals leverages natural marine substances in its research, with chemists and biologists optimizing molecules derived from marine organisms to create effective kinase inhibitors. This approach underscores the company's commitment to advancing medical treatments and improving patient care in areas of significant unmet need.
Dracula Technologies SAS specializes in the design and manufacture of organic photovoltaic cells aimed at providing energy autonomy for connected devices. Founded in 2011 and based in Valence, France, the company develops products that enable small electronic devices, such as phones, GPS units, and lamps, to self-recharge using solar energy. Their flagship product, Light As Your Energetic Response (LAYER), is designed to capture various forms of light, both indoors and outdoors, and convert it into usable energy through advanced digital printing techniques. The team consists of approximately 20 members, including a scientific committee and an administrative committee, all dedicated to fostering innovation and collaboration within the company. Dracula Technologies operates as a subsidiary of Ardeje.
PeekMed is a 3D pre-operative planning system for orthopedic surgery that aims to help the surgeon better treat the patient while reducing costs. With PeekMed the surgeon can plan: - Total Joint Replacements; - Osteotomies; - Fracture reductions; - Virtually any orthopedic procedure. The output of PeekMed system can later be used as an input for: - Navigation systems; - 3D printers; - Robotics; - Mobile devices. PeekMed was founded by Jaime Campos, Sara Silva, and João Pedro Ribeiro in 2015 and is located in Braga, Portugal.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Connecting Food is a foodtech company based in Paris, France, that specializes in a blockchain-based platform for real-time tracking and auditing of food products. Established in 2016, the company offers LiveAudit, an application that allows digital auditing of product quality throughout the entire production process. This platform enables consumers, particularly those purchasing eggs, to access detailed information about the hen's breed, the farm of origin, and the packing location. By leveraging blockchain technology, Connecting Food provides a transparent supply chain solution that fosters trust among farmers, manufacturers, retailers, and consumers, thereby enhancing brand equity and ensuring the integrity of agricultural and finished products.
Novolyze, SAS is a French company that specializes in food safety solutions for the global food processing industry. Established in 2012 and headquartered in Daix, with an additional office in Cambridge, Massachusetts, Novolyze provides a comprehensive range of equipment, including steam pasteurizers, sterilizers, dryers, roasters, extruders, and ovens. The company is also known for its innovative surrogate microorganisms technology, which allows food manufacturers to test the effectiveness of microbial kill steps under real-life conditions. In addition to its equipment offerings, Novolyze provides services in pasteurization, regulatory compliance, and process validation, as well as food microbiology research to a diverse clientele that includes large corporations, small and medium enterprises, public and private research laboratories, and food processing associations. With a strong emphasis on enhancing food safety and quality, Novolyze employs a team of experts, including food microbiologists and process engineers, and operates state-of-the-art facilities in a pharmaceutical-grade environment for research and development.
Ignion is an antenna innovator that creates a multiband, multipurpose and ready-to-use antenna. The company was founded in 2015 and is based in Sant Cugat del Vallès, Spain.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
Ignion is an antenna innovator that creates a multiband, multipurpose and ready-to-use antenna. The company was founded in 2015 and is based in Sant Cugat del Vallès, Spain.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Saalg Geomechanics is owner and operator of an engineering company intended to offer specialized advanced geological and numerical services. The company offers numerical model calibrations and soil and rock parameters characterization by backanalysis and inverse analysis, 2D and 3D geomechanical and geotechnical simulations, manily for TBM Tunnel Excavations, Conventional Tunnels, Large and deep excavations, reinforced earth retaining walls and wellbore stabity analysis, enabling their customers to build a bridge between academic research in the field of geomechanics and the industry.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.
Spartha Medical is a medical technology company focused on developing eco-friendly, invisible coatings designed for medical devices and consumer products to mitigate microbial and inflammatory risks. Utilizing natural biopolymers, the company’s innovative coatings possess antibacterial, antiviral, and anti-inflammatory properties, providing an effective solution for infection control. The technology relies on a patented method of supramolecular assembly, enabling precise control over the properties of the coatings based on specific applications. This approach allows for the creation of multifunctional and easy-to-apply surface treatments that help healthcare institutions maintain disease-free environments on medical devices.
Amadix is focused on developing and commercializing innovative cancer diagnostic technologies that address unmet medical needs in oncology. The company's flagship product, Colofast, is a non-invasive screening signature for colorectal cancer and advanced adenoma diagnosis, aimed at reducing the high mortality rate associated with colon cancer. Amadix's approach emphasizes early detection, allowing for timely treatment while avoiding the complications of invasive procedures like tumor biopsies. The team comprises industry veterans with extensive expertise in oncology diagnostics, the pharmaceutical industry, and biotechnology, supported by independent board members who provide strategic guidance in commercialization and business development, particularly in Europe and the United States. Amadix's products undergo rigorous analytical validation and clinical studies before being introduced to the global market.
Multiverse Computing SL develops software for the finance industry. It develops software for solving financial and macro-economic problems. The company was incorporated in 2019 and is based in San Sebastian, Spain with an additional office in Toronto, Canada.
Multiverse Computing SL develops software for the finance industry. It develops software for solving financial and macro-economic problems. The company was incorporated in 2019 and is based in San Sebastian, Spain with an additional office in Toronto, Canada.
From smartphones to connected cars, location data is changing the way we live and the way business happens. CARTO is the platform that turns spatial data into more efficient delivery routes, better behavioral marketing, strategic store placements, and much more. Data Scientists, Developers, and Analysts solve spatial problems using CARTO’s data and analysis to understand where and why things happen, optimize business processes, and predict future outcomes through the power of Spatial Data Science. Backed by leading VC firms Accel Partners, Salesforce Ventures, Earlybird Ventures, and Kibo Ventures, CARTO is the world’s leading Location Intelligence platform. Founded in 2012 by an environmental scientist and visualization experts, CARTO is headquartered in New York City with offices in Madrid, Seville and Washington DC. CARTO has a team of 130 employees, a portfolio of 2,500 customers including BBVA, BCG, New York City, and Twitter and more than 350,000 users around the globe - and has regularly been recognized by Gartner and Forrester for its innovation in the Location Intelligence space.
Perha Pharmaceuticals is a biotechnology company dedicated to the research and development of innovative therapies aimed at addressing hearing loss and cognitive disorders. The company focuses on preventing cisplatin-induced hearing loss and developing treatments for cognitive conditions related to Down syndrome and Alzheimer's disease. Perha Pharmaceuticals leverages natural marine substances in its research, with chemists and biologists optimizing molecules derived from marine organisms to create effective kinase inhibitors. This approach underscores the company's commitment to advancing medical treatments and improving patient care in areas of significant unmet need.
Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
enGenome is a bioinformatics company provides accurate omics-based reports to physicians, thus improving diagnosis and treatment processes for patients. Their products and services helps to improve the diagnosis of genetic diseases and patients therapies by producing accurate genetic reports.
Palobiofarma S.L. is a biotechnology company based in Barcelona, Spain, with an additional facility in Navarra. Founded in 2005, the company specializes in the discovery and development of new drugs that target adenosine receptors, with a focus on treating advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, Palobiofarma aims to be the first European company to market a selective adenosine receptor modulator, addressing significant medical needs through innovative therapeutic approaches.
Simplicity Works develops its patented technology 3D Bonding - the simplest method for joining pieces.
ThrustMe is a startup emerging from the Laboratoire de Physique des Plasmas at the Ecole Polytechnique and the CNRS, founded by Ane Aanesland and Dmytro Rafalskyi. The company specializes in the development, production, and commercialization of next-generation space propulsion systems utilizing its patented technology. With a focus on simplifying and enhancing the efficiency of electric propulsion, ThrustMe provides tailored solutions for both next-generation satellites and ground testing of space hardware. This approach supports space teams and aerospace businesses in achieving economic and environmental sustainability through advanced propulsion options, addressing the evolving needs of the satellite industry and the growing demand for data and global intelligence.
A word About US.A bunch of visionary people. Scientific scouts. Daring entrepreneurs. Just a crew of dreamers, all with a common goal. Improving Human Experience.They give a Key to interact with the world through your imagination & our technology. Is a new way to play with the environment. Mountains. Trees. Clouds. Flowers. Rivers. Rocks. Animals. Waves. People. Friends. And a new way to show your feelings. flying, exploring, Surfing & Underwater.
SiPearl is a semiconductor company that commercializes the work of the European Processor Initiative (EPI) and bring a low-power microprocessor to market for exascale supercomputing. The company aims to design, market, and distribute its first range of processors with a commercial launch in 2022 based on a roadmap closely aligned with the European Union’s goals. It has already committed to producing its chips using N6 or better processes from TSMC. It was founded in 2019 and headquartered in Maisons-Laffitte, Île-de-France.
Palobiofarma S.L. is a biotechnology company based in Barcelona, Spain, with an additional facility in Navarra. Founded in 2005, the company specializes in the discovery and development of new drugs that target adenosine receptors, with a focus on treating advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, Palobiofarma aims to be the first European company to market a selective adenosine receptor modulator, addressing significant medical needs through innovative therapeutic approaches.
Producer of food ingredients intended to provide upcycled ingredients for nutrition. The company's fermentation platform transforms wasted fruit and vegetable by-products into low-carb flour with improved nutritional value and functionality, enabling clients to get flour that is high in protein and dietary fiber, while being low in starch, sugars, and fats.
MYSPHERA SL specializes in providing innovative location and process visibility solutions for the healthcare sector through the Internet of Things (IoT) and real-time location systems (RTLS). Founded in 2012 and based in Paterna, Spain, the company develops a range of IoT devices and applications designed to enhance patient care and resource management in acute care hospitals, senior living facilities, and patient homes. Its offerings include tracking devices, alert systems, and environmental sensors, along with web applications such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare providers in managing services effectively. MYSPHERA's solutions aim to improve patient outcomes and operational efficiency by delivering actionable information to clinicians, patients, and healthcare management across Europe, the Middle East, and Latin America.
Epigene Labs SAS, founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, develops a biotechnology platform that harnesses advanced artificial intelligence to transform genomic data into actionable insights for precision oncology. The platform addresses the challenges of aggregating, analyzing, and visualizing extensive genomic datasets, which are crucial for advancing precision oncology. By integrating proprietary data from partners with publicly available information, Epigene Labs provides medical researchers with user-friendly analytics and insights that facilitate drug development and research in cancer treatment. The company focuses on forming value-based partnerships with leading cancer centers and prominent biotech firms to enhance the efficacy of oncology solutions.
MYSPHERA SL specializes in providing innovative location and process visibility solutions for the healthcare sector through the Internet of Things (IoT) and real-time location systems (RTLS). Founded in 2012 and based in Paterna, Spain, the company develops a range of IoT devices and applications designed to enhance patient care and resource management in acute care hospitals, senior living facilities, and patient homes. Its offerings include tracking devices, alert systems, and environmental sensors, along with web applications such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare providers in managing services effectively. MYSPHERA's solutions aim to improve patient outcomes and operational efficiency by delivering actionable information to clinicians, patients, and healthcare management across Europe, the Middle East, and Latin America.
A word About US.A bunch of visionary people. Scientific scouts. Daring entrepreneurs. Just a crew of dreamers, all with a common goal. Improving Human Experience.They give a Key to interact with the world through your imagination & our technology. Is a new way to play with the environment. Mountains. Trees. Clouds. Flowers. Rivers. Rocks. Animals. Waves. People. Friends. And a new way to show your feelings. flying, exploring, Surfing & Underwater.
Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable insights for various sectors, including academic research, plant and animal breeding, and biomedicine. Sequentia collaborates with over 30 public and private research centers, universities, and companies, participating in more than 160 research and development projects. The company offers a range of services, including cloud software, custom software solutions, and bioinformatics consulting, aimed at advancing healthcare, agriculture, and environmental sciences. Sequentia Biotech also maintains two open-source biodata banks and has developed an award-winning research initiative called Tricopharming. The founders have contributed significantly to the field, with over 40 scientific publications in prestigious journals.
Powder is a startup that helps to share video clips of favorite games, follow people with the same interests and interact with them.
Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable insights for various sectors, including academic research, plant and animal breeding, and biomedicine. Sequentia collaborates with over 30 public and private research centers, universities, and companies, participating in more than 160 research and development projects. The company offers a range of services, including cloud software, custom software solutions, and bioinformatics consulting, aimed at advancing healthcare, agriculture, and environmental sciences. Sequentia Biotech also maintains two open-source biodata banks and has developed an award-winning research initiative called Tricopharming. The founders have contributed significantly to the field, with over 40 scientific publications in prestigious journals.
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
Roka Furadada mission is to reduce the incidence of skin cancer through research, development, and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact.
UPMEM is implementing the first scalable, programmable and efficient Processing-In-Memory (PIM) solution for the datacenter.
In server architectures, Big Data processing performance is limited by data movements. UPMEM solution accelerates 10+ times data-intensive applications with an innovative solution based on a large number of programmable co-processors located next to the data.
Voiseed is an AI-based company founded in 2020 and headquartered in Milan, Italy, specializing in the development of a virtual voice engine for speech synthesis. The company's software utilizes advanced generative AI technologies to replicate human emotions and prosody, creating highly expressive virtual voices. Voiseed's cloud-based platform offers a universal voice model and an emotional data set, allowing users to customize vocal expressions and perform multilingual voice conversions for various projects. This innovative tool enables creators in the dubbing industry to design voice textures that meet their specific requirements, significantly reducing costs, time, and complexity in the production process.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
Lactips is a French company founded in 2014 and headquartered in Lyon. It specializes in manufacturing biodegradable and water-soluble thermoplastic pellets derived from milk protein. The company employs a proprietary industrial process to produce these pellets quickly and in high volumes, making them suitable for various applications, including thermoforming and films. Lactips aims to offer its industrial clients innovative and sustainable alternatives to traditional oil-based plastics, aligning with its commitment to environmental sustainability and efficiency. By providing these disruptive solutions, Lactips supports its clients in accessing new markets while promoting a cleaner and more sustainable approach to plastic usage.
Oledcomm S.A.S. is a company based in Paris, France, that specializes in the design and manufacture of Li-Fi (light fidelity) network interface devices, which facilitate high-speed wireless data communication. Established in 2005, Oledcomm offers a range of products including Li-Fi routers, hubs, switches, and accessories tailored for various applications such as indoor location services, Internet of Things connectivity, and communication in sectors like telecom, datacom, personal electronics, and industrial markets. Their product lineup includes the GEOLiFi LED router and LiFiNET routers, along with development kits and the LiFiCLOUD platform. Oledcomm's solutions cater to diverse environments including museums, retail spaces, hospitals, offices, and smart cities, emphasizing environmentally friendly wireless communication.
bound4blue specializes in the development of innovative foldable and autonomous wingsail systems designed for integration into a variety of vessels. This technology serves as a complementary propulsion system, harnessing wind power to generate thrust and significantly reducing the reliance on main engine power. As a result, bound4blue's wingsails can lead to reductions in fuel consumption and pollutant emissions by up to 40%. In addition to improving environmental sustainability, the system offers a payback period of less than five years, making it an economically viable option for boat operators. The technology also facilitates the production of hydrogen and oxygen through the electrolysis of seawater, further enhancing its eco-friendly credentials.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
NEOS Surgery S.L. is a Barcelona-based company specializing in the research, design, development, and commercialization of implantable medical devices for neurosurgery. Founded in 2003, NEOS focuses on innovative solutions for cranial and spinal surgical applications, including its proprietary BHID cranial fixation system, which is designed for placement in the burr hole of a craniotomy. The company is committed to meeting the needs of neurosurgeons and patients, ensuring its products are both effective and compliant with stringent quality standards, including ISO certifications. By capturing market demands, NEOS aims to create high-value medical devices that enhance surgical outcomes and contribute to advancements in the neurosurgery field.
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters. The platform has redesigned floating wind platforms to reduce costs by 50percent and weight 80percent while expanding the operation depth range in comparison to other floating solutions. It has less active systems than current designs and can be fully assembled at the port and then installed using a small tug boat. X1 Wind helps to achieve a radical weight reduction in floating wind structures to current semi-submersible and spar systems. It was founded in 2017 and is based in Barcelona, Spain.
SILEANE specialists of robotics and vision.
X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters. The platform has redesigned floating wind platforms to reduce costs by 50percent and weight 80percent while expanding the operation depth range in comparison to other floating solutions. It has less active systems than current designs and can be fully assembled at the port and then installed using a small tug boat. X1 Wind helps to achieve a radical weight reduction in floating wind structures to current semi-submersible and spar systems. It was founded in 2017 and is based in Barcelona, Spain.
Separative is a startup bringing a break in the purification of molecules in organic chemistry and peptides.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
CarThera SAS specializes in the design and development of therapeutic ultrasound-based medical devices aimed at treating brain disorders. Founded in 2010 and headquartered in Paris, France, the company has developed innovative devices such as SonoProbe, which addresses conditions like brain tumors, epilepsy, metastases, and meningioma. Another key product is SonoCloud, an intracranial ultrasound implant that temporarily opens the blood-brain barrier, enhancing the delivery and concentration of therapeutic molecules for the treatment of primary brain tumors. Through these advancements, CarThera is focused on improving treatment outcomes for patients with serious neurological conditions.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
VoltAero is a manufacturer of electric aircraft that focuses on providing safe, quiet, and eco-friendly flight solutions. The company specializes in parallel electric-hybrid propulsion systems, allowing for efficient and reliable general aviation platforms. Its aircraft cater to a variety of uses, including private ownership, air taxi and charter services, and commercial flights for regional travel. By developing innovative electric aircraft, VoltAero aims to enable clients to embrace a new era of sustainable aviation.
Unblur is a technology company based in Barcelona, Spain, founded in 2015, that focuses on developing AI software for public emergency services, including firefighters, civil protection, and police. Its primary offering is IRIS, a modular software-as-a-service platform designed to enhance incident command. The platform centralizes data and tools, providing incident commanders with real-time situational awareness throughout the various stages of an incident. This capability enables emergency service organizations to improve their operational response and make informed decisions during critical situations, ultimately enhancing coordination among teams and effectiveness in emergency management.
Unblur is a technology company based in Barcelona, Spain, founded in 2015, that focuses on developing AI software for public emergency services, including firefighters, civil protection, and police. Its primary offering is IRIS, a modular software-as-a-service platform designed to enhance incident command. The platform centralizes data and tools, providing incident commanders with real-time situational awareness throughout the various stages of an incident. This capability enables emergency service organizations to improve their operational response and make informed decisions during critical situations, ultimately enhancing coordination among teams and effectiveness in emergency management.
TomaPaint specializes in the production of bio-resins derived from by-products of industrial tomato processing. The company focuses on creating an organic-based lacquer designed for use in food packaging, particularly for the internal coating of food cans. This innovative lacquer serves as an ecological alternative to traditional synthetic petrochemical-based resins, aiming to transform the metal food packaging industry. By utilizing waste recycling and cutin extraction, TomaPaint contributes to significant environmental and health benefits, enabling industries to lower carbon emissions and minimize the use of hazardous chemicals.
Altaroad SAS is a French company founded in 2017 that specializes in developing a SaaS-based application for real-time vehicle data capture. The company employs patented nano-sensors embedded in roadways alongside advanced algorithms to analyze and generate critical road data. This technology enables the monitoring of traffic patterns, tracking of vehicle weights, assessment of road impacts, and detection of unsafe driving behaviors. Altaroad's platform supports traffic management in smart cities by identifying maintenance needs, enhancing predictive maintenance for road operators, and facilitating cost savings for logistics providers. Additionally, the system can quickly recognize hazardous conditions, such as icy pavements, and provide feedback for autonomous vehicles, contributing to safer and more efficient road usage.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Ability Pharmaceuticals, S.L. is a clinical stage biopharmaceutical company based in Barcelona, Spain, dedicated to the discovery and development of human therapeutics for cancer and other unmet medical needs. The company specializes in creating Lipid Analogue Therapeutics, a novel class of small molecules designed to be administered orally. Its primary focus is on developing treatments for lung, pancreatic, and gynecological cancers. The development pipeline includes ABTL0812, which targets the Akt/mTOR signaling pathways, and ABTL0815, currently in preclinical characterization. Ability Pharmaceuticals develops its drug candidates up to clinical proof of concept before out-licensing them to pharmaceutical companies for further development. Founded in 2009, the company was formerly known as AB Therapeutics, S.L. and changed its name in September 2012.
SOMAprobes S.L. develops healthcare technology for magnetic resonance imaging detection of bacterial pathogens at the onset of infectious disease. The company was incorporated in 2014 and is based in Donostia, Spain.
Revolutionary electromagnetic endoscopy accessory to automatize polyp detection
ADmit Therapeutics, S.L. is a biotechnology company based in Begues, Spain, dedicated to the development of diagnostic tests for the early detection of Alzheimer’s disease. Founded in 2017, the company utilizes epigenetic analysis of blood samples to identify a series of mitochondrial biomarkers that are not related to traditional indicators such as ß-amyloid or tau proteins. By analyzing a large number of methylcytosines in mitochondrial DNA through next-generation sequencing, ADmit Therapeutics provides a novel and accessible method for medical practitioners to detect early-stage Alzheimer’s disease. Their innovative approach primarily serves pharmaceutical companies, aiming to enhance diagnostic capabilities in the field of neurodegenerative diseases.
Revolutionary electromagnetic endoscopy accessory to automatize polyp detection
Xenothera SAS is a biotechnology company based in Nantes, France, focused on advancing immunological treatments through its innovative platform. Established in 2014, the company specializes in developing therapeutic solutions targeting various medical areas, including immunomodulation and infectious diseases. Its approach leverages proprietary Glyco-Humanized Antibodies and integrates expertise in animal genetics and immunology to create a new generation of hyperimmune polyclonal sera. By renovating passive immunotherapy, Xenothera aims to address unmet medical needs and facilitate the rapid development of new immunological therapies. The company's comprehensive platform allows for streamlined processes, from selecting immunogens to purifying immunoglobulins, ultimately aiming for expedited market authorization.
PKvitality is a bio-wearable company based in Paris, France, founded in 2017. The company has developed K’Track, a line of trackers that utilize its patented SKinTaste technology to analyze physiological markers through non-invasive skin testing, eliminating the need for blood samples. One of its flagship products, K’Watch Glucose, enables diabetic individuals to monitor their glucose levels continuously and conveniently, without the discomfort associated with traditional blood tests. The wearable device features a sensor that requires no calibration, provides a comprehensive data history, and sends alerts to users to remind them to check their glucose levels, enhancing the self-monitoring experience for diabetic patients.
Cinfo specializes in cloud-based automated video production services that cater to various enterprises equipped with venues and broadband connections. The company installs smart cameras at these venues, allowing for the creation and broadcasting of high-quality videos, either live or on-demand, to a range of devices including mobile phones, web browsers, smart TVs, and virtual reality platforms. Cinfo's technology enhances viewer experiences through multi-camera setups and immersive virtual reality capabilities while also providing valuable tools for sports organizations and coaches to analyze training footage and improve competitions. Beyond sports, Cinfo's systems have been adopted in sectors such as aeronautics and corporate communications, where they serve to stream IoT data and facilitate multi-country management and press conferences, respectively.
CorWave SA is a medical device company based in Clichy, France, specializing in the development and manufacture of heart-assist pumps. Founded in 2011, CorWave focuses on innovative technologies to improve patient outcomes in advanced heart failure. Its flagship product, the CorWave Left Ventricular Assist Device (LVAD), employs a unique undulating disc wave pumping mechanism that mimics the natural pulsatile flow of the heart, significantly reducing trauma to the blood and minimizing complications such as clotting and bleeding. This technology contrasts with traditional continuous flow pumps, which lack significant pulsation. Additionally, the company offers Nemo, a minimally invasive cardiac pump designed for patients who are not candidates for LVADs, providing chronic, partial support. CorWave's devices are characterized by low power consumption and compact design, which may enable total implantability with wireless energy transfer systems.
Nimesis SAS develops, manufactures, and markets memory alloys on copper and nickel-titanium in France and internationally. Its products include round or flat wires, thin ribbons, and beta 3 alloys. The company also offers smelting works, transformation, characterization, and engineering and design services to companies. Its products are used in medical, automobile, aerospace, aeronautical, clock industry, jewelery, and Microsystems industrial sectors. The company was founded in 2004 and is based in Metz, France.